Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Is there a best Avastin-containing regimen for first line and maintenance therapy in advanced NSCLC?
Do you need Avastin in first line and maintenance therapy in advanced NSCLC?
Dr. Phil Bonomi: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?
Can we predict which patients will benefit from Tarceva based on a blood test?
Drs. Ross Camidge and Corey Langer: How Do You Make Use of a Broad Molecular Profile Brought by a Patient?
Is there a role for molecular markers predicting the best chemotherapy to use in lung cancer?
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Current and Future Treatments (video)
Is it possible to test for biomarkers in lung cancer on a national scale?
Dr. Greg Riely: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Dr. Geoffrey Oxnard: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Rosalyn Juergens on "My Approach to Maintenance Therapy for Advanced NSCLC"
Dr. Sarah Goldberg on "Which patients do you send molecular marker testing for?"
Dr. Ravi Salgia: What is Your Opinion of Patients and Caregivers Searching the Internet for Information?
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (video)
Dr. David Spigel: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?
Dr. Heather Wakelee: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Dr. Greg Riely: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Phil Bonomi: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?
Dr. Karen Kelly: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (video)
Create your
podcast in
minutes
It is Free
Good Mood Revolution
GRACEcast Pancreatic Cancer Audio
GRACEcast Radiation Oncology Audio
GRACEcast Head and Neck Cancer Video NEW
GRACEcast Kidney Cancer Video
GRACEcast Social Work and Coping Video